Production of bioactive oligosaccharides
US-11066684-B2 · Jul 20, 2021 · US
US12492219B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12492219-B2 |
| Application number | US-202017616554-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 2, 2020 |
| Priority date | Jun 5, 2019 |
| Publication date | Dec 9, 2025 |
| Grant date | Dec 9, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Synthetic oligosaccharides and mixtures thereof which resemble polysaccharides produced by plants, yeast and other fungi, bacteria, and algae are described. The oligosaccharides and compositions provided herein are useful as synbiotics, prebiotics, immune modulators, digestion aids, and food additives.
Opening claim text (preview).
What is claimed is: 1 . A composition comprising synthetic oligosaccharides, wherein the synthetic oligosaccharides comprise seven or more oligosaccharide molecules selected from the group consisting of: Glcβ1-3Glcβ1-4Glcβ1-4Glcβ1-4Glc, Glcβ1-4Glcβ1-3Glcβ1-4Glcβ1-4Glc, Glcβ1-4Glcβ1-4Glcβ1-3Glcβ1-4Glc, Glcβ1-3Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-4Glc, Glcβ1-4Glcβ1-3Glcβ1-4Glcβ1-4Glcβ1-4Glc, Glcβ1-4Glcβ1-4Glcβ1-3Glcβ1-4Glcβ1-4Glc, Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-3Glcβ1-4Glc, and Glcβ1-3Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-3Glc. 2 . The composition of claim 1 , further comprising one or more oligosaccharide molecules selected from the group consisting of: Glcβ1-4Glcβ1-3Glc, Glcβ1-3Glcβ1-4Glc, Glcβ1-3Glcβ1-4Glcβ1-4Glc, Glcβ1-4Glcβ1-3Glcβ1-4Glc, Glcβ1-4Glcβ1-4Glcβ1-3Glc, Glcβ1-3Glcβ1-4Glcβ1-3Glc, Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-3Glc, and Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-3Glc. 3 . The composition of claim 2 , further comprising: Glcβ1-4Glcβ1-3Glc, Glcβ1-3Glcβ1-4Glc, Glcβ1-3Glcβ1-4Glcβ1-4Glc, Glcβ1-4Glcβ1-3Glcβ1-4Glc, Glcβ1-4Glcβ1-4Glcβ1-3Glc, Glcβ1-3Glcβ1-4Glcβ1-3Glc, Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-3Glc, and Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-3Glc. 4 . The composition of claim 1 , further comprising any 7 or more of the oligosaccharide molecules of: Glcβ1-4Glcβ1-3Glc, Glcβ1-3Glcβ1-4Glc, Glcβ1-3Glcβ1-4Glcβ1-4Glc, Glcβ1-4Glcβ1-3Glcβ1-4Glc, Glcβ1-4Glcβ1-4Glcβ1-3Glc, Glcβ1-3Glcβ1-4Glcβ1-3Glc, Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-3Glc, and Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-4Glcβ1-3Glc. 5 . The composition of claim 1 , wherein the synthetic oligosaccharides are derived from depolymerization of β-glucan, lichenan, oat bran, wheat bran, or any combination thereof. 6 . The composition of claim 5 , wherein the depolymerization comprises oxidative treatment with hydrogen peroxide and a transition metal or alkaline earth metal, followed by based induced cleavage. 7 . The composition of claim 1 , wherein the synthetic oligosaccharides are present in an amount of 90 wt. % to 99 wt. %, based on total weight of oligosaccharides in the composition. 8 . The composition of claim 1 , wherein the composition is in a form of a foodstuff, a nutritional supplement, a synbiotic, an excipient, or a pharmaceutical product. 9 . The composition of claim 1 , further comprising one or more xylose-containing oligosaccharide molecules selected from the group consisting of: (Araα1-3)Xylβ1-4Xyl, Xylβ1-4 (Araα1-3)Xyl, ((Araα1-2) (Araα1-3))Xyl, Xylβ1-4Xylβ1-4Xyl, (Araα1-3)Xylβ1-4Xylβ1-4Xyl, Xylβ1-4 (Araα1-3)Xylβ1-4Xyl, Xylβ1-4Xylβ1-4 (Araα1-3)Xyl, (Araα1-3)Xylβ1-4 (Araα1-3)Xyl, ((Araα1-2) (Araα1-3))Xylβ1-4Xyl, Xylβ1-4 ((Araα1-2) (Araα1-3))Xyl, Xylβ1-4Xylβ1-4Xylβ1-4Xyl, Xylβ1-4 [Xylβ1-4] 3 Xyl, Xylβ1-4 [Xylβ1-4] 4 Xyl, Xylβ1-4 [Xylβ1-4] 5 Xyl, or Xylβ1-4 [Xylβ1-4] 6 Xyl. 10 . The composition of claim 9 , wherein the synthetic oligosaccharides are selected from of any 2 or more of the xylose-oligosaccharide molecules. 11 . The composition of claim 9 , wherein the synthetic oligosaccharides are selected from of any 3 or more of the xylose-oligosaccharide molecules. 12 . The composition of claim 9 , wherein the synthetic oligosaccharides are selected from of any 4 or more of the xylose-oligosaccharide molecules. 13 . The composition of claim 9 , wherein the synthetic oligosaccharides are selected from of any 10 or more of the xylose-oligosaccharide molecules.
Addition of substantially indigestible substances, e.g. dietary fibres · CPC title
beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof · CPC title
Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof · CPC title
beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof · CPC title
Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.